MD Mednax Inc

Price (delayed)

$14.13

Market cap

$1.17B

P/E Ratio

353.25

Dividend/share

N/A

EPS

$0.04

Enterprise value

$1.88B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The debt has decreased by 33% YoY and by 12% from the previous quarter
The equity is up by 3.8% QoQ
The P/E is 102% above the last 4 quarters average of 175.3
The company's EPS has shrunk by 85% YoY and by 78% QoQ

Key stats

What are the main financial stats of MD
Market
Shares outstanding
83.03M
Market cap
$1.17B
Enterprise value
$1.88B
Valuations
Price to earnings (P/E)
353.25
Price to book (P/B)
1.32
Price to sales (P/S)
0.6
EV/EBIT
15.06
EV/EBITDA
11.72
EV/Sales
0.95
Earnings
Revenue
$1.97B
EBIT
$124.84M
EBITDA
$160.47M
Free cash flow
$137.23M
Per share
EPS
$0.04
Free cash flow per share
$1.64
Book value per share
$10.73
Revenue per share
$23.63
TBVPS
$9.55
Balance sheet
Total assets
$2.35B
Total liabilities
$1.46B
Debt
$717.08M
Equity
$891.63M
Working capital
$1.01M
Liquidity
Debt to equity
0.8
Current ratio
1
Quick ratio
0.94
Net debt/EBITDA
4.41
Margins
EBITDA margin
8.1%
Gross margin
23.7%
Net margin
3.4%
Operating margin
8.8%
Efficiency
Return on assets
2.8%
Return on equity
7.6%
Return on invested capital
9.9%
Return on capital employed
6.5%
Return on sales
6.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
1.51%
1 week
-1.26%
1 month
-9.65%
1 year
-38.73%
YTD
-4.91%
QTD
-4.91%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.97B
Gross profit
$467.03M
Operating income
$172.69M
Net income
$66.34M
Gross margin
23.7%
Net margin
3.4%
The net margin has plunged by 51% YoY and by 21% from the previous quarter
The net income has declined by 49% year-on-year and by 21% since the previous quarter
The operating margin has declined by 17% year-on-year and by 16% since the previous quarter
MD's operating income is down by 16% since the previous quarter and by 15% year-on-year

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
353.25
P/B
1.32
P/S
0.6
EV/EBIT
15.06
EV/EBITDA
11.72
EV/Sales
0.95
The P/E is 102% above the last 4 quarters average of 175.3
The company's EPS has shrunk by 85% YoY and by 78% QoQ
The P/B is 31% below the last 4 quarters average of 1.9 and 27% below the 5-year quarterly average of 1.8
The equity is up by 3.8% QoQ
The stock's price to sales (P/S) is 50% less than its 5-year quarterly average of 1.2 and 25% less than its last 4 quarters average of 0.8
The revenue has increased by 3.2% YoY

Efficiency

How efficient is Mednax business performance
MD's return on equity has dropped by 52% year-on-year and by 22% since the previous quarter
The company's return on sales fell by 47% YoY and by 22% QoQ
The ROA has contracted by 44% YoY and by 18% from the previous quarter
The ROIC is down by 37% YoY and by 15% from the previous quarter

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 61% greater than the total liabilities
The quick ratio has declined by 49% year-on-year and by 16% since the previous quarter
The company's current ratio fell by 49% YoY and by 17% QoQ
The debt is 20% less than the equity
MD's debt to equity is down by 33% year-on-year and by 16% since the previous quarter
The debt has decreased by 33% YoY and by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.